Register entry
- Registered sites
- 0
- Active NDC listings
- 36
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3636 active NDC listings: 36 human prescription drug. By marketing category: NDA 36.
| Dosage form | NDCs |
|---|---|
| capsule | 15 |
| solution | 15 |
| film | 4 |
| system | 2 |
| Route | NDCs |
|---|---|
| oral | 34 |
| topical | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| ibsa pharma inc. | 36 |
Catalogue
Marketed products
36| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FLECTOR | diclofenac epolamine | system, topical | 71858-0405NDA |
| LICART | diclofenac epolamine | system, topical | 71858-0305NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0005NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0010NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0012NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0013NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0015NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0017NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0020NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0025NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0030NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0035NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0040NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0045NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0050NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0055NDA |
| Tirosint | levothyroxine sodium | capsule, oral | 71858-0060NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0105NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0110NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0112NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0113NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0115NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0117NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0120NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0125NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0130NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0135NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0140NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0145NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0150NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0155NDA |
| Tirosint SOL | Levothyroxine Sodium | solution, oral | 71858-0160NDA |
| Vybrique | sildenafil citrate | film, oral | 71858-0205NDA |
| Vybrique | sildenafil citrate | film, oral | 71858-0210NDA |
| Vybrique | sildenafil citrate | film, oral | 71858-0215NDA |
| Vybrique | sildenafil citrate | film, oral | 71858-0220NDA |
Compare
Other companies listing levothyroxine sodium
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Lupin Limited14 sites · 506 NDC
- AbbVie Inc.13 sites · 131 NDC
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Fresenius Kabi USA, LLC6 sites · 561 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
Enquiry
Common questions
- Is IBSA Pharma Inc. FDA approved?
- IBSA Pharma Inc. holds no registered establishment of its own; 36 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does IBSA Pharma Inc. make?
- 36 products are listed under IBSA Pharma Inc. in the openFDA NDC Directory, most often as capsule; solution; film. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.